Durata Therapeutics, Inc. Research and Development Expense
Durata Therapeutics, Inc. reported Research and Development Expense of $11.27 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-11-07
- Durata Therapeutics, Inc. research and development expense for the quarter ending 2014-09-30 was $11.27M, a 90.06% increase year-over-year.
- Durata Therapeutics, Inc. research and development expense for the quarter ending 2014-06-30 was $6.19M, a 53.06% decline year-over-year.
- Durata Therapeutics, Inc. research and development expense for the quarter ending 2014-03-31 was $9.01M, a 18.78% decline year-over-year.
- Durata Therapeutics, Inc. research and development expense for the quarter ending 2013-12-31 was $7.12M, a 24.60% decline year-over-year.
- Durata Therapeutics, Inc. research and development expense for fiscal 2013 was $37.32M, a 27.81% decline from fiscal 2012.
- Durata Therapeutics, Inc. research and development expense for fiscal 2012 was $51.70M, a 71.56% increase from fiscal 2011.
- Durata Therapeutics, Inc. research and development expense for fiscal 2011 was $30.13M, a 525.42% increase from fiscal 2010.
- Durata Therapeutics, Inc. research and development expense for fiscal 2010 was $4.82M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 32 month | Research and Development Expense 35 month | Research and Development Expense 38 month | Research and Development Expense 41 month | Research and Development Expense 44 month | Research and Development Expense 47 month | Research and Development Expense 50 month | Research and Development Expense 53 month | Research and Development Expense 56 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $11.27M 10-Q · filed 2014-11-07 | $17.45M derived: sum of 2 quarters · filed 2014-11-07 | $26.46M 10-Q · filed 2014-11-07 | $33.58M derived: sum of 4 quarters · filed 2014-11-07 | |||||||||||||
| 2014-06-30 | $6.19M 10-Q · filed 2014-08-07 | $15.19M 10-Q · filed 2014-08-07 | $22.31M derived: sum of 3 quarters · filed 2014-08-07 | $28.24M derived: sum of 4 quarters · filed 2014-11-07 | $139.35M 10-Q · filed 2014-08-07 | ||||||||||||
| 2014-03-31 | $9.01M 10-Q · filed 2014-05-08 | $16.13M derived: sum of 2 quarters · filed 2014-05-08 | $22.05M derived: sum of 3 quarters · filed 2014-11-07 | $35.23M derived: sum of 4 quarters · filed 2014-11-07 | $133.17M 10-Q · filed 2014-05-08 | ||||||||||||
| 2013-12-31 | $7.12M 10-K · filed 2014-03-14 | $13.05M derived: sum of 2 quarters · filed 2014-11-07 | $26.23M derived: sum of 3 quarters · filed 2014-11-07 | $37.32M 10-K · filed 2014-03-14 | $124.16M 10-K · filed 2014-03-14 | ||||||||||||
| 2013-09-30 | $5.93M 10-Q · filed 2014-11-07 | $5.93M 10-Q · filed 2013-11-06 | $19.11M derived: sum of 2 quarters · filed 2014-11-07 | $30.20M 10-Q · filed 2014-11-07 | $30.20M 10-Q · filed 2013-11-06 | $39.64M derived: sum of 4 quarters · filed 2014-11-07 | $117.04M 10-Q · filed 2013-11-06 | ||||||||||
| 2013-06-30 | $13.18M 10-Q · filed 2014-08-07 | $13.18M 10-Q · filed 2013-08-07 | $24.27M 10-Q · filed 2014-08-07 | $24.27M 10-Q · filed 2013-08-07 | $33.71M derived: sum of 3 quarters · filed 2014-08-07 | $52.67M derived: sum of 4 quarters · filed 2014-08-07 | $111.11M 10-Q · filed 2013-08-07 | ||||||||||
| 2013-03-31 | $11.09M 10-Q · filed 2014-05-08 | $11.09M 10-Q · filed 2013-05-09 | $20.53M derived: sum of 2 quarters · filed 2014-05-08 | $39.49M derived: sum of 3 quarters · filed 2014-05-08 | $56.02M derived: sum of 4 quarters · filed 2014-05-08 | $97.94M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | $9.44M 10-K · filed 2014-03-14 | $9.44M 10-K · filed 2013-03-08 | $28.40M derived: sum of 2 quarters · filed 2014-03-14 | $44.92M derived: sum of 3 quarters · filed 2014-03-14 | $51.70M 10-K · filed 2014-03-14 | $51.69M 10-K · filed 2013-03-08 | $86.84M 10-K · filed 2013-03-08 | ||||||||||
| 2012-09-30 | $18.96M 10-K · filed 2014-03-14 | $18.96M 10-Q · filed 2012-11-09 | $35.48M derived: sum of 2 quarters · filed 2014-03-14 | $42.25M 10-Q · filed 2013-11-06 | $51.29M derived: sum of 4 quarters · filed 2014-03-14 | $77.40M 10-Q · filed 2012-11-09 | |||||||||||
| 2012-06-30 | $16.53M 10-K · filed 2014-03-14 | $16.53M 10-Q · filed 2012-09-04 | $23.30M 10-Q · filed 2013-08-07 | $32.34M derived: sum of 3 quarters · filed 2014-03-14 | $40.66M derived: sum of 4 quarters · filed 2014-03-14 | $58.45M 10-Q · filed 2012-09-04 | |||||||||||
| 2012-03-31 | $6.77M 10-K · filed 2014-03-14 | $6.77M 10-K · filed 2013-03-08 | $15.81M derived: sum of 2 quarters · filed 2014-03-14 | $24.14M derived: sum of 3 quarters · filed 2014-03-14 | $32.57M derived: sum of 4 quarters · filed 2014-03-14 | ||||||||||||
| 2011-12-31 | $9.04M 10-K · filed 2013-03-08 | $17.36M derived: sum of 2 quarters · filed 2013-03-08 | $25.80M derived: sum of 3 quarters · filed 2013-03-08 | $30.13M 10-K · filed 2014-03-14 | $30.13M 10-K · filed 2013-03-08 | ||||||||||||
| 2011-09-30 | $8.33M 10-K · filed 2013-03-08 | $16.76M derived: sum of 2 quarters · filed 2013-03-08 | $21.09M 10-Q · filed 2012-11-09 | ||||||||||||||
| 2011-06-30 | $8.44M 10-K · filed 2013-03-08 | $12.77M 10-Q · filed 2012-09-04 | |||||||||||||||
| 2011-03-31 | $4.33M 10-K · filed 2013-03-08 | ||||||||||||||||
| 2010-12-31 | $4.82M 10-K · filed 2013-03-08 |